Muteins of human erythropoietin, the preparation thereof and the use thereof
Patent 5457089 Issued on October 10, 1995. Estimated Expiration Date: July 6, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/8, Glycoprotein (carbohydrate containing)424/85.1, LYMPHOKINE435/69.4, Hormones and fragments thereof514/1225 or more peptide repeating units in known peptide chain structure
The invention relates to muteins of human erythropoietin (EPO) in the carboxyl terminal region which are prepared by means of recombinant DNA techniques. These mutants have advantageous properties in comparison with human wild-type EPO.
Other References
Rolson et al. 1986. Introduction to Protein and Protein Engineering, Elsevier, New York, N.Y. p. 41
Jacobs et al., Nature, 313:806-809 (1985)
Dordal et al., Endocrinology, 116:2293-2299 (1985)
Letsinger et al., J. Amer. Chem Soc., 97:3278-3279 (1975)
Letsinger et al., J. Amer. Chem Soc., 98:3655-3661 (1976)
Morinaga et al., Bio/Technology, 7:636-639 (1984)
Kramer et al., Nucl. Acids. Res. 12:9441-9456
Sanger et al., Proc. Natl. Acad. Sci., USA 74:5463-5467 (1977)
Zettlmeissl et al., Behring Inst. Mitt., 82:26-34 (1988)
Graham et al., Virology, 52:456-467 (1973)
Lee et al., Nature (London), 294:228-232 (1981)
Hudziak et al., Cell, 31:137-146 (1982)
Hales et al., Biochem., J., 88:137-146 (1983)
Tejedor et al., Analyt. Biochem., 127:143-149 (1982)
Smith et al., Analyt. Biochem., 150:76-85 (1985)
Krystal, J. Exp. Hematol., 11:649-660 (1983)
Recny et al., J. Biol. Chem., 262:17156-63 (1987)
Bowie et al. 1990. Science 247:1306-1310
Dayhoff et al. 1972. Atlas of Protein Sequence and Structure vol. 5 89-99
Shoemaker et al. 1986. Molecular and Cellular Biology 6(3): 849-858
Dube et al. 1988. J. Biol. Chem. 263(33): 17516-17521
Rege et al. 1982. J. Lab Clin Med., 100(6): 829-84